Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Connect Biopharma Holdings Ltd ADR (NQ: CNTB ) 1.350 -0.060 (-4.26%) Streaming Delayed Price Updated: 3:59 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Connect Biopharma Holdings Ltd ADR < Previous 1 2 3 4 5 6 Next > Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024 September 10, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal September 07, 2024 EpimAb Biotherapeutics sold global rights for a clinical-stage asset to Vignette Bio, a San Francisco startup, in a $635 million deal. Meanwhile, Shenzhen TargetRx raised $20 million by selling China... Via Talk Markets Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update September 05, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum July 01, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 13, 2024 Via Benzinga Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 12, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire Connect Biopharma Announces New Leadership and Chair of the Board of Directors June 12, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma May 22, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma May 07, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update April 16, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session April 03, 2024 Via Benzinga Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference March 19, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 20, 2024 Via Benzinga Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors February 12, 2024 From Connect Biopharma Holdings Limited Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session February 02, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session December 29, 2023 Via Benzinga Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal December 16, 2023 SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb in a $8.4 billion agreement. Via Talk Markets Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket December 12, 2023 Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 12, 2023 Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading! Via InvestorPlace Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma December 12, 2023 From Connect Biopharma Holdings Limited Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session December 11, 2023 Via Benzinga Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023 December 11, 2023 From Connect Biopharma Holdings Limited Via GlobeNewswire Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management November 30, 2023 Dallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to... Via Newsfile Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston’s Ensem November 25, 2023 Beijing’s BeiGene acquired global rights to a preclinical novel cyclin-dependent kinase 2 (CDK2) inhibitor from Boston’s Ensem Therapeutics in a $1.3 billion agreement. Ensem will receive an upfront... Via Talk Markets Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 22, 2023 Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Via Benzinga Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket November 22, 2023 Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 22, 2023 Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning! Via InvestorPlace Why Is Skin Disease-Focused Connect Biopharma Stock Lower Today? November 21, 2023 Connect Biopharma Holdings Limited (NASDAQ: CNTB) released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's (formerly known as CBP-201) efficacy... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session November 21, 2023 Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.